Canada markets closed

Enlivex Therapeutics Ltd. (ENLV)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.4400-0.0500 (-3.36%)
At close: 04:00PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-28,607
-29,068
-31,060
-14,468
-11,824
-
Depreciation & amortization
706
835
777
546
286
-
Stock based compensation
3,650
1,951
2,712
2,914
670
-
Change in working capital
-928
-1,818
804
-1,357
-306
-
Accounts Payable
25
-1,121
1,168
442
36
-
Other working capital
-32,300
-23,759
-32,075
-19,167
-12,026
-
Other non-cash items
844
4,940
831
413
167
-
Net cash provided by operating activites
-25,726
-23,523
-23,953
-17,542
-11,007
-
Cash flows from investing activities
Investments in property, plant and equipment
-6,574
-236
-8,122
-1,625
-1,019
-
Purchases of investments
-15,688
-26,166
-1,907
-104,417
-19,958
-
Sales/Maturities of investments
82,316
301
72,553
67,634
0
-
Other investing activites
-
-
-
-
-
1,544
Net cash used for investing activites
60,054
-25,968
62,524
-38,408
-20,977
-
Cash flows from financing activities
Common stock issued
0
360
0
53,174
24,467
-
Net cash used privided by (used for) financing activities
147
360
150
60,982
33,082
-
Net change in cash
34,475
-49,131
38,721
5,032
1,098
-
Cash at beginning of period
23,327
50,357
11,636
7,012
5,524
-
Cash at end of period
57,802
1,226
50,357
11,636
7,012
-
Free Cash Flow
Operating Cash Flow
-25,726
-23,523
-23,953
-17,542
-11,007
-
Capital Expenditure
-6,574
-236
-8,122
-1,625
-1,019
-
Free Cash Flow
-32,300
-23,759
-32,075
-19,167
-12,026
-